Advertisements



Alpine Immune Sciences: Digging Into A Recent Newcomer Onto The Immunotherapy Scene

Alpine Immune Sciences: Digging Into A Recent Newcomer Onto The Immunotherapy Scene.....»»

Category: topSource: seekingalphaOct 11th, 2018

Alpine Immune Sciences initiated with an Overweight at Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 27th, 2018

Alpine Immune Sciences initiated with an Outperform at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2018

Alpine Immune Sciences hires Alder co-founder as president and operations chief

Alder Biopharmaceuticals, the the Puget Sound region's third-largest biotech, has lost two of its three founders in the last six and hired new leaders......»»

Category: topSource: bizjournalsAug 7th, 2018

Alpine Immune Sciences appoints Mark Litton as COO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 6th, 2018

Rounds Report: Alpine Immune Sciences Broke The Trend In A Down Market

Rounds Report: Alpine Immune Sciences Broke The Trend In A Down Market.....»»

Category: topSource: seekingalphaJul 18th, 2018

Alpine Immune Sciences started at outperform with $13 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 29th, 2018

Alpine Immune Sciences initiated with an Outperform at Oppenheimer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

Alpine Immune Sciences: What The Q1 2018 Earnings Foretell?

Alpine Immune Sciences: What The Q1 2018 Earnings Foretell?.....»»

Category: topSource: seekingalphaJun 7th, 2018

Alpine Is A Buy Ahead Of Clinical Trials, Wedbush Says In Positive Initiation

Wedbush analysts see an attractive entry point for Alpine Immune Sciences Inc. (NASDAQ: ALPN), as the biotech's initial candidates will enter the clinic over the next year. Latest Ratings fo.....»»

Category: blogSource: benzingaMay 18th, 2018

Wedbush starts Alpine Immune Sciences with Outperform, $13 target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2018

Alpine Immune Sciences initiated at outperform at Wedbush

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 18th, 2018

Alpine Immune Sciences initiated with an Outperform at Wedbush

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2018

Immune Design"s stock plummets toward record low after cancer vaccine program discontinued

Shares of Immune Design Corp. took a 42% dive toward a record low in premarket trade Friday, after the immunotherapy company said it discontinued its CMB305 cancer vaccine program. The company said late Thursday it made the design a.....»»

Category: topSource: marketwatchOct 12th, 2018

Alpine Immune sees having sufficient cash to fund operations into 2020

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 9th, 2018

Alpine Immune reports Q2 EPS (57c), consensus (43c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 9th, 2018

Why Huya Has Been Immune To The Recent Setbacks For Chinese Streaming Companies

Why Huya Has Been Immune To The Recent Setbacks For Chinese Streaming Companies.....»»

Category: topSource: seekingalphaAug 3rd, 2018

Exact Sciences" stock drops sharply as Madison company misses analysts" projections

Exact Sciences Corp., the maker of the Cologuard stool DNA-based colorectal cancer take-home test, saw a 78 percent increase in revenue for its recent second quarter when compared with the year-ago quarter, but still missed analysts' revenue projections......»»

Category: topSource: bizjournalsAug 2nd, 2018

ThinkChicago has opened college students’ eyes to the city’s tech scene. The Lollapalooza tickets don’t hurt

In the effort to recruit recent college graduate.....»»

Category: topSource: chicagotribuneAug 2nd, 2018

Atara Biotherapeutics Announces Second Quarter 2018 Financial Results and Recent Operational Progress

SOUTH SAN FRANCISCO, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, aut.....»»

Category: earningsSource: benzingaAug 1st, 2018

The 13 best horror movie directors working today who terrify us over and over again

Universal The horror movie genre has seen a surplus of fresh talent in recent years, including newcomer Ari Aster, whose chilling feature directorial debut "Hereditary" is in theaters now. And with that talent has come a.....»»

Category: topSource: businessinsiderJun 25th, 2018